An interventional study of Intrapulmonary Percussive Ventilation in Respiratory Distress Syndrome in Premature Infant, sponsored by Augusta University. Not yet recruiting. Open to participants aged 14 Days and older. Per ClinicalTrials.gov, last updated 2024-01-31.
Sponsored by Augusta University · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the benefits and safety of Intrapulmonary Percussive Ventilation in preterm infants. IPV has been demonstrated to be safe, and improve airway secretions clearance and decreased atelectasis in pediatric patients. We aim to evaluate the effects of IPV in preterm infants.
1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.
This study's planned enrollment of 10 is below the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.
Browse Respiratory Distress Syndrome studies →Augusta University is the lead sponsor of 177 studies on the registry; 24 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 3 (30%) have results posted.
Counted across the registry records on this site, refreshed daily.
INCLUSION CRITERIA
Device: Intrapulmonary Percussive Ventilation
IPV applied at increasing intervals, starting every 6 hours, and ending at every 24 hours, for a total of 7 days.
Mechanical ventilation and supplemental oxygen
Need for mechanical ventilation and supplemental oxygen administration
Time frame: From the date of starting treatment protocol to 2 weeks after.
Diagnosis of Bronchopulmonary Dysplasia
Need for mechanical ventilation and supplemental oxygen administration
Time frame: At 36 weeks gestational age
No study locations are listed for this record.
This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome→
Augusta University